We're here today with Sue Bajaj of Uvo Health. Sue is the CTO.
Sue, thank you for joining us today.
Thanks, Jordan. I appreciate you having me on.
Sure. So.
But the conversation.
For our listeners, you vote is a health tech startup based in New
York City, providing value based contracting and administrative
support to community health centers, including federally
qualified health centers, which for the rest of this episode
will be referring to as FQHC's. Sue. I'd like to kick off the
conversation by discussing.
You know the the intersection Yuvo was at the intersection of
HealthEquity and technology. I think many of our listeners are
interested in health disparities, diversity, equity
and inclusion, and the topic of HealthEquity more generally,
would you be able to give us an overview of what yuvo is doing
in this area of the healthcare sector?
Sure, sure it be. Be happy to. So YUVO was founded a couple of
years ago in 21 and more recently in 22 had had
contracted with some FQHC's in downstate New York.
Umm. And you know our our mantra, our goal at at Yuvo
halls is really to be inclusive where a bipod founded
organization and in that many of the founders you know grew up
using FQHC's. And so this really means a lot for folks to be able
to enable FQHC's in the HealthEquity space, but also
just really enable FQHC's to take on value based care. That's
really what you vote does.
A part of that, of course, is HealthEquity. And looking at
what we can do from a technology standpoint to be able to enable
FQHC's to do more with this Medicaid population. So largely
there's a more more prevalent Medicaid population in FQHC's
and for our listeners, FQHC's can be essentially where there's
not a lot of other available options for patients to go to a
clinic.
Whether it's really rural, deeply urban just, you know, in
different areas and that's where FQHC's fill the void, there's
about 1400 of them nationally. So there's quite a large
footprint.
Umm Yuvo is looking at this from the standpoint of, you know,
over the last few years there's been many adapted technologies
adopted technologies because of COVID. But even prior to COVID
some interesting stats that you know, Deloitte had done a survey
back in 2018 showing that Medicaid, the Medicaid
population was at about 86% adoption with smartphones. And I
remember when I saw that back in 2018-2019 and I thought wow,
that's really untapped potential.
Umm, in terms of, you know what we can do to enable the Medicaid
population and then COVID happened, right?
Umm. And we were all focused on how do we do outreach to various
populations through telemedicine using smartphones using tablets
and other other modalities. And I think the way that you was
looking at this from a product standpoint is how do we use the
86% population in and grow that so that we can leverage other
modalities of care along with the FQHC. So enable the FQHC's.
With telehealth remote patient monitoring, some of these other
other capabilities and that's really what we're looking to do,
we're startup. We just started all these things. We're kind of
excited to get going on them, but but that's the direction
that we're headed in.
Because, Sue, I, I'd like to take a step back here, so I
Around this. Yeah, go ahead.
asked about technology and intersection of HealthEquity. We
spoke a bit about the Medicaid population and and where they
potentially are, but I'd like to ask you to define areas of
health disparities. What what is, what does HealthEquity mean?
What is not equitable that?
What? Where? What are the hot topic issues in within the
context of HealthEquity in America today?
Yeah, man, I think there's there's a few. One would be, you
know, access to care, access to seeing a clinician when it's
needed and you know, being able to get to a clinician. So for
example, not having a car and having an urgent emergent
situation. So it might be after hours and you're in a place
where you can't go see a primary care doc or there's not urgent
cares. You know, I live in a suburb, there's an urgent care
at every corner.
That's not the case for a lot of our FQHC patients. And so they
end up in the Ed or the ER, which is not the right place
for, you know, this, this kind of this kind of care. It's
really needs to be redirected to primary care. So that's an area
of of health inequity, right. Another area would be when
you're looking at what are the drivers of high utilization,
it's for a large part of the population in terms of health
inequity.
It's really things like consistent food, homelessness,
you know those, those those drive quite a bit of the health
and equity. You know if I don't have a place to to hang my hat,
I'm certainly not worried about taking my medicines on time. I
may not have a place for them. I may not be able to pick them up
even though in Medicaid, you know they it's from the
standpoint of you can go to a pharmacy and edit without
payment. However, if I've inconsistent housing that ends
up becoming a problem. So really the definition here is.
We have folks that don't have the same access that the rest of
us do in terms of.
Umm.
I'm a a home food.
Access to care and necessarily to be able to manage. And so if
they have chronic conditions or even if they don't have chronic
conditions and they just have other issues going on, it
exacerbates the situation.
Where you know they're they're not able to manage, manage
themselves and end up in the ER and Ed, et cetera.
So when I think of health disparities, I I heard you say
basically food and homelessness, I'd categorize under
socioeconomic status. SES you said access, beneath which there
Right.
was urgent care, transportation, timely access, that's all under
the umbrella of access.
Interestingly, I did not, and that all seems basically to to
seem to be financial indicators, but I did not hear you mention
race or age, which are often considered to be areas where
health disparities are measured. Care to comment?
Yeah, absolutely. And that that's like, you know, something
that absolutely you see the skew for you know, other races, non
Caucasian races, that there is a greater disparity in access to
care in in some of these other other items I've mentioned. So
what ends up happening is an outcomes really. So when you
look at infant mortality, we all have heard that black mothers
have much higher infant mortality.
And much higher rate of something happening to them when
they're delivering a child or postmortem post postpartum.
Excuse me, then you know others. So absolutely. Age and race
play.
You know a a role in this as well and I think FQHC's are are
very much there and the localities to help address those
as well. And that's where I think again technology.
You know, I I come from a tech background. I'm the CTO here at
Yuvo. I do think of tech in a lot of ways as a great equalizer
in allowing us to do outreach and allowing us to do some
things that create access that create knowledge about what's
going on with somebody that we otherwise wouldn't be able to
know. It's not perfect. Of course. There's inherent biases
right in technology because of who designs technology, right?
By and large, technology is not driven and designed by women.
By you know non, non, non Caucasian folks. It's it's
actually driven mostly predominantly by white males.
And that does create bias and technology. Yuvo is looking at
things differently again and wants to focus on how do we use
technology enable technology to with FQS with patients to sort
of close the gaps in in that in those.
In those access issues, yeah.
Yeah.
Sue, let's dive a bit deeper right here. I'd like to ask what
specifically is being done to reduce disparities and enhance
equity using technology as a platform.
Yeah. I think one of one of the key things that's being done is
you know driving patient care to.
Telehealth and and telemedicine and I think there was a great
uptick, you know about 17% of Medicaid patients during COVID
were using telehealth and telemedicine.
In various ways, and there was, you know, greater utilization
just because centers were closed and or if they were open limited
hours, limited clinicians available, et cetera. So there
was a greater drive towards that at the time. And then of course,
once you know, we all opened our doors, full-fledged everyone
sort of gone back to even though they have smartphones, even
though they have access have gone back to wanting to see
folks in person, there's a preference there.
Umm.
But I think again, when you're looking at managing chronic
conditions and you're looking at managing non acute conditions,
telehealth is a fantastic way in order for us to do outreach to
patients and to schedule patients that otherwise might be
turned to a more acute, higher acute center, right, that isn't
necessarily gonna solve their problems because in the end,
they do need to come back to their primary care doc. In the
end, they do need to come back to their specialist.
In the end, they do need to see somebody who's going to help
manage their conditions and the the LED visit where the urgent
care visit is is more avoidable.
UM, then we think by leveraging these these technologies and so
that's an area that we're looking at because we see that
this keeps growing and how do we partner with FQ to enable them
to do telehealth and expand telehealth hours along with, of
course, you know there's there's health plans in the mix here who
offer some of this in the third leg of the stool here is patient
knowledge, right. So patients may not know. OK, I did this
during COVID.
But they may not realize that, hey, this is still a capability
that I have and rather than me walking down to the ER, I can. I
can actually just, you know, log into an app and see somebody for
my flu or for me to manage my condition. That's one way.
It.
Sorry, go ahead.
It sounds like a lot of what you just discussed in terms of
actions that can be concretely taken using tech to reduce
disparities include providing lower acuity care in the form of
telehealth or telemedicine in order to address chronic
conditions and reduce readmissions and therefore
increase shared savings with value based payment plans. Is
that an accurate representation?
Yeah, you nailed it. Exactly. Exactly. That's one of the ways.
Perfect I.
Yeah. Yeah.
I heard you differentiate between telehealth and
telemedicine. Would you mind elaborating for a moment on a
difference between the two?
Yeah. I think folks do use that interchangeably and I do as well
use it. You know it. It means different things to different
folks. But I think that there's an aspect of the quick I've got
the flu, right. And and I've done this, I've done this with
my my children where you know they've got something and it's
not. It's not very cute, but I would like them to see somebody
and it's after hours and you know, I don't. I don't wanna
take them to urgent care or to the ER.
It's not necessary, and so you make a decision from, you know,
a telehealth. You download a telehealth app, pick one right
and and whatever is in network with your health plan and you
and you go for it and it works great. Whereas you know the
other telemedicine, this is more of a.
And again, I do this as well with one of my clinicians who's
in the city. I can't get to her very often. She's managing a
condition with me and I every other visit instead of going in.
It's way more convenient for her and me. We talk 15 minutes. We
have a chat. See how things are going and that's another Ave.
right for really managing chronic conditions. And I think
the differentiator in my mind may not be true for everybody.
Is this sort of low acute? I've got the flu.
Got you know some, some minor cold type of thing, but I do
wanna be seen and and maybe get get some help around it.
And be triage, because maybe that along with chronic
conditions could be something right worse. But the other side
of this is if I'm trying to manage a chronic condition on a
regular basis, and my practitioner does not have the
bandwidth to, you know, have me come in and vice versa, I don't
have access to go in, I don't have a car, I don't have access
to go in. This enables the patient then to feel confident
Right.
that hey, once a month or once every two months, I'm gonna have
this call.
And it's a face to face that get to see my clinician, we get to
talk about what's going on and how managing my care, yeah.
2.
Would it be fair to say that telehealth is ad hoc and
telemedicine is more regular?
Yeah, I I would say that I hope, I hope it's just not my
Perfect.
definition, but I've I've heard it a few times, but I yeah.
Great.
I we still have a lot of some ground to cover before the end
of this episode and few different issues I'd like to
cover. One thing that occurred to me is I'd like to ask, in
your opinion, in your experience, what does diversity
look like within the Medicaid population? Again, this is
getting back to financial, race, age, and sex, but also I'm
wondering with the recession and periodic unemployment, I'm
wondering if maybe white collar professionals who find
themselves.
How to work for seven months and up in that time going from
employer sponsored health insurance coverage down into
uninsured and and and and and then Medicaid and then go back
into normal white collar professional jobs. And I'm
wondering what the impact is on that like cyclical or kind of
one time temporary?
A unemployment or or professional? Yeah, a gaps in
care gaps in coverage I'd say.
Yeah. And and I think we saw some of that right with COVID
where COVID expanded Medicaid by about 10 million folks
organically where we didn't have redeterminations. And you've,
you've probably heard that there's gonna be roll offs of
you know, since the PBE is officially declared as over and
you are looking at, you know, losing this this 10 million and
a lot of those folks are looking to.
Health plans are being allowed to help them enroll either re
enroll in Medicaid or help them enroll in ACA plans, or just
kind of unheard of, right? This is a new thing, and I think
Umm.
that's great. And you make a great point because there is a
socioeconomic factor here, right? Is it skewed to words,
you know, certain certain sections of the population? Yes,
absolutely. But there's a lot of folks that are. This ends up
being a socioeconomic problem as well. Just just as it was in
COVID, where there was a layoffs.
Umm and folks, you know, lost jobs didn't have insurance
coverage and we, you know, accepted them into Medicaid with
no redeterminations like we normally do annual
redeterminations that's been going on for almost three years.
So I think we've seen that. I think that it worked really
well, but it definitely overwhelmed systems that were
already overwhelmed and add in COVID which which was
overwhelming systems.
Again, that's where I think having, you know telehealth,
telemedicine come into play and other you know we we haven't
talked yet about some of these other technologies that we're
looking at but.
I I think that can be a game changer for a lot of folks who
are trying to manage conditions and have, you know, have lost
insurance and don't know can I don't know what to do and there
are gonna come into they are gonna come into Medicaid that
Yeah.
have the right income to come into Medicaid and or into
subsidized ACA programs.
What are some of those other tech solutions that you just
referenced?
Yeah. So some of these other ones that I think you know that
I think we just started to see especially you've you've heard a
lot of these like digital health startups, right, that we're
managing weight or managing a variety of different things like
autoimmune disease or other chronic conditions. But I think
we just are at the tipping point, not even just just
starting maybe at the tipping point there around these M
health apps that sort of give people a community, right. So
now many of them need to be vetted, right for us and who we
partner with, but.
Looking at for example, you know telehealth or telemedicine for
specialty care where we have an opportunity for folks who need
specialists, could they use? Could they use some of these M
health apps to improve medication adherence, manage
chronic conditions and again be more preventative because they
need specialists that maybe aren't readily available. And
the FQS, they're most definitely not, but they have to go
outside. It's hard to get. It's hard to get appointments,
etcetera.
And and the other part of it is, it gives them a community,
right? I don't know if you've ever used any of these M health
apps, but you know, I have and it gives you a community of
folks who have similar chronic conditions and gives you an
opportunity to discuss, even talk about nutrition, talk about
a variety of things to help you manage your conditions. So I
think, again, the third leg of the stool is always education.
And how do we get patients to adopt? How do we incentivize
them to use these and then measure?
Right, so was this useful? Did this help us?
To really manage this patient, how did the patient work? You
know, how did the patient use this? Now? Some of these health
apps, they're they're measuring things like clicks and
interaction, which isn't the best. You know, I've I've, I've
used some of these, which isn't the best way to say, OK,
somebody's sticking to something. It it doesn't
necessarily mean that. I think it ends up being kind of a false
positive. We need to really look at outcomes for these for these
apps and outcomes with these patients. But I think, again,
that's a very underutilized ecosystem.
That has really been, at this point more direct to consumer
and it hasn't been brought into the Medicaid population at
large. I'm not saying we're using it yet, but it's something
that we're definitely considering as well.
So Sue, I've been enjoying this conversation. However, we are
approaching the end of this podcast episode. As such, I'd
like to pose a final question to you and invite you to elaborate
where you see most, where you have the most interest. My
question is, given that our audience is mostly large health
systems, CIOs, how can large health systems best partner with
FQHC's and serve this Medicaid or perhaps dual eligible,
meaning Medicaid and Medicare population?
Yeah, I think I think at the end of the day, there's a few ways.
I think there's this data that's really important for us to help
manage these patients. So I think as you know, their
admitted and I think we we see them being admitted or even pre
admission where there's a planned admission, right,
there's some some instances where there is a planned
admission, especially with we have a large population of
pregnant women.
And I think in the Medicaid population again, there's real
opportunity to partner with health systems with this
population and.
Uh, you know postpartum care in, in the actual, you know, birth
and and exchange of data between us and them and that hey, we
have all this information about this patient that's walking
through your door. Right and partnering with you so that you
understand what their primary care has been working with them
on what are the conditions they may have etcetera. And then even
in postpartum. So in follow up of postpartum care for us.
And with the health system, where they may be coming back in
to see their OB, et cetera. And I think there's a real
opportunity even if we start there with.
You know women, women who are delivering kind of well in
advance of delivery so that we are giving the health system the
opportunity to see our curated data which which we work on to
say, OK, these are the conditions, this is this, these
are some of the social determinants of health for this
patient that we have readily available. So as they walk into
the door and they're delivering at your system, you're you're
more well versed, your clinicians are more well versed
and what's actually happening. So I think I think data is the
core of it and there's a real opportunity to.
To to work together around it.
Well, I love ending on that note. Sue would like to remind
our listeners this has been sue Bajaj, the CTO of Yuvo health
tech startup in New York City. Sue, thank you very much for
joining us today.
OK, great. Thank you.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.